SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-015444
Filing Date
2022-04-25
Accepted
2022-04-25 16:44:22
Documents
6
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tcon-def14a_20220614.htm DEF 14A 981858
2 GRAPHIC gf04vpqnji4h000004.jpg GRAPHIC 85677
3 GRAPHIC gf04vpqnji4h000001.jpg GRAPHIC 12234
4 GRAPHIC gf04vpqnji4h000003.jpg GRAPHIC 24558
5 GRAPHIC gf04vpqnji4h000005.jpg GRAPHIC 58437
6 GRAPHIC gf04vpqnji4h000002.jpg GRAPHIC 24558
  Complete submission text file 0001564590-22-015444.txt   1266726
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36818 | Film No.: 22850267
SIC: 2836 Biological Products, (No Diagnostic Substances)